A significant correlation of galectin-3 expression was observed with tumor progression in overall cases, and in poorly differentiated adenocarcinoma the expression of galectin-3 in metastatic lymph nodes was stronger than the primary cancer [25]. Here, LGALS3 is linked to cancer.